Merck
CN
Search Within

117-57-7

应用筛选条件
关键词:'117-57-7'
显示 1-6 共 6 条结果 关于 "117-57-7" 范围 论文
Mahsa M Amoli et al.
The Journal of rheumatology, 30(9), 2019-2022 (2003-09-11)
To assess the influence of endothelial nitric oxide synthase (eNOS) polymorphisms in the susceptibility to giant cell arteritis (GCA). We studied 57 patients with biopsy-proven GCA diagnosed at the Rheumatology Division of Hospital Xeral-Calde and 117 ethnically matched controls. Patients
Yao-Yuan Hsieh et al.
Genetic testing and molecular biomarkers, 15(12), 841-847 (2011-08-11)
Asthma, one major respiratory consequence, might be caused by a complex interaction between multiple candidate genes and environmental factors. Herein, we aimed to investigate whether Janus kinase (JAK)-1 gene polymorphisms are associated with asthma susceptibility. Patients were divided into two
Eva Sullivan et al.
Critical care medicine, 42(1), 48-56 (2013-08-22)
To determine the differential association of host characteristics, antimicrobial resistance, and type III secretion system virulence of Pseudomonas aeruginosa isolates with respiratory syndromes in hospitalized adult patients. Retrospective, cohort study. Community teaching hospital. Two hundred eighteen consecutive adult patients with
S Whittaker et al.
The British journal of dermatology, 167(3), 678-687 (2012-08-29)
Psoralen plus ultraviolet A (PUVA) is the standard treatment for early stages of mycosis fungoides. There have been no adequate randomized controlled trials with sufficient power comparing this modality with other therapies. To assess disease response and to compare the
T R Leonard et al.
American journal of physiology. Cell physiology, 299(6), C1398-C1401 (2010-09-17)
It has been accepted for half a century that, for a given level of activation, the steady-state isometric force of a muscle sarcomere depends exclusively on the amount of overlap between the contractile filaments actin and myosin, or equivalently sarcomere
Emilie Lalonde et al.
The Lancet. Oncology, 15(13), 1521-1532 (2014-12-03)
Clinical prognostic groupings for localised prostate cancers are imprecise, with 30-50% of patients recurring after image-guided radiotherapy or radical prostatectomy. We aimed to test combined genomic and microenvironmental indices in prostate cancer to improve risk stratification and complement clinical prognostic
1/1